Fatma Levent, MD

Pediatric Infectious Diseases Specialist

Pediatrics Research

Expertise of Fatma Levent, MD

Biography: Fatma Levent, MD, is a board-certified pediatric infectious diseases specialist. She was an assistant professor at the Texas Tech Health Sciences Center where she lectured on a wide range of infectious disease topics. Dr. Levent holds certifications from the American Board of Pediatrics including xSub-Board of Pediatric Infectious Diseases and is a member of the Pediatric Infectious Diseases Society and the Society of Healthcare Epidemiology of America.
Education: Cukurova University, Faculty of Medicine, Adana, Turkey
Residency: Texas Tech University Health Sciences Center, Lubbock, TX
Fellowship: Pediatric Infectious Diseases at Baylor College of Medicine, Houston, TX
Board Certifications: American Board of Pediatrics

Publications

Uncommon aetiology of lymphadenopathy in a healthy child: a sporotrichosis case with painless lymphadenopathy

2022, BMJ CASE REPORTS

View publication for "Uncommon aetiology of lymphadenopathy in a healthy child: a sporotrichosis case with painless lymphadenopathy"
Atrioventricular Conduction Abnormalities in Multisystem Inflammatory Syndrome in Children

2021, CASE REPORTS IN PEDIATRICS

View publication for "Atrioventricular Conduction Abnormalities in Multisystem Inflammatory Syndrome in Children"
Screening Awareness of HPV-Related Oropharyngeal Cancers and Attitudes and Concerns towards HPV Vaccination Among Parents HPV and Oropharyngeal Cancer

2021, JOURNAL OF CANCER EDUCATION

View publication for "Screening Awareness of HPV-Related Oropharyngeal Cancers and Attitudes and Concerns towards HPV Vaccination Among Parents HPV and Oropharyngeal Cancer"

More sources loaded
Burkholderia cepacia Sepsis in a Previously Healthy Full-Term Infant

2020, CASE REPORTS IN PEDIATRICS

View publication for "Burkholderia cepacia Sepsis in a Previously Healthy Full-Term Infant"
How to Treat Cytomegalovirus-induced Hemophagocytic Lymphohistiocytosis in a Child With Leukemia

2020, JOURNAL OF PEDIATRIC HEMATOLOGY ONCOLOGY

View publication for "How to Treat Cytomegalovirus-induced Hemophagocytic Lymphohistiocytosis in a Child With Leukemia"
CASE OF A PEDIATRIC SPINAL DORSAL DERMAL SINUS TRACT WITH SPINAL ABSCESS AND RECURRENT MENINGITIS

2020, JOURNAL OF INVESTIGATIVE MEDICINE

View publication for "CASE OF A PEDIATRIC SPINAL DORSAL DERMAL SINUS TRACT WITH SPINAL ABSCESS AND RECURRENT MENINGITIS"
AN UNCOMMON ETIOLOGY OF SEPTIC SHOCK IN A TERM INFANT

2020, JOURNAL OF INVESTIGATIVE MEDICINE

View publication for "AN UNCOMMON ETIOLOGY OF SEPTIC SHOCK IN A TERM INFANT"
NOT JUST ANOTHER VIRUS: LEUKOPENIA AND TRANSAMINITIS IN AN 18-MONTH-OLD MALE

2020, JOURNAL OF INVESTIGATIVE MEDICINE

View publication for "NOT JUST ANOTHER VIRUS: LEUKOPENIA AND TRANSAMINITIS IN AN 18-MONTH-OLD MALE"
CHRONIC GRANULOMATOUS HSV ENCEPHALITIS IN A PRESCHOOL CHILD

2020, JOURNAL OF INVESTIGATIVE MEDICINE

View publication for "CHRONIC GRANULOMATOUS HSV ENCEPHALITIS IN A PRESCHOOL CHILD"
HYBRIDIZED PEDAGOGY: A NOVEL APPROACH TO TEAACHING GLOBAL HEALTH AND TROPICAL MEDICINE

2020, JOURNAL OF INVESTIGATIVE MEDICINE

View publication for "HYBRIDIZED PEDAGOGY: A NOVEL APPROACH TO TEAACHING GLOBAL HEALTH AND TROPICAL MEDICINE"

More Publication Information

Associated Clinical Trials for Fatma Levent, MD

NCT04223752

A Phase 1, open-label, non-comparative, multicenter clinical study to evaluate the safety, tolerability, and pharmacokinetics of ceftolozane/tazobactam (MK-7625A) in pediatric participants with nosocomial pneumonia

This study is currently enrolling.

Research Area: Pediatrics Research

Research Location: Orlando, Florida

Ceftolozane/tazobactam, also known as Zerbaxa, is a combination product, and is available by prescription for use in adults for the treatment of complicated urinary tract infections, including...

More clinical trials loaded

Fatma Levent, MD

Expertise of Fatma Levent, MD

Associated Clinical Trials for Fatma Levent, MD

A Phase 1, open-label, non-comparative, multicenter clinical study to evaluate the safety, tolerability, and pharmacokinetics of ceftolozane/tazobactam (MK-7625A) in pediatric participants with nosocomial pneumonia